AD

Andrew Evan Denker

Merck: 5 patents #2,116 of 9,382Top 25%
EC Eisai R&D Management Co.: 2 patents #329 of 817Top 45%
AP Alexion Pharmaceuticals: 1 patents #110 of 226Top 50%
DT Dynavax Technologies: 1 patents #27 of 52Top 55%
TS Trisalus Life Sciences: 1 patents #6 of 20Top 30%
📍 Boston, MA: #1,241 of 5,993 inventorsTop 25%
🗺 Massachusetts: #20,307 of 88,656 inventorsTop 25%
Overall (All Time): #793,195 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12083112 Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer Yu Kato, Kimiyo Tabata, Yusaku Hori 2024-09-10
11918648 Combination of a PD-1 antagonist and CpG-C type oligonucleotide for treating cancer Ying Yu, Svetlana Sadekova, Uyen Phan, Robert A. Kastelein, David KAUFMAN +3 more 2024-03-05
11547705 Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer Yu Kato, Kimiyo Tabata, Yusaku Hori 2023-01-10
11224637 Methods for treating hypophosphatasia (HPP) in adults and adolescents Scott Edward Moseley, Wei-Jian Pan 2022-01-18
10751412 Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer Ying Yu, Svetlana Sadekova, Uyen Phan, Robert A. Kastelein, David KAUFMAN +3 more 2020-08-25
8338458 Method of treatment using fused aromatic compounds having anti-diabetic activity Peter T. Meinke, Gary E. Meininger, Naoto Uemura, John A. Wagner, Steven Charnick 2012-12-25